Calcium channel blockers revisited

Hong Kong Medical Journal

Volumn 8, Issue 4, 2002, Pages 300-301

  Cheung, B M Y ^a   Kumana, C R ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE; VERAPAMIL; ANTIHYPERTENSIVE AGENT;

ANGINA PECTORIS; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; HEART ARRHYTHMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; NOTE; OUTCOMES RESEARCH; PRACTICE GUIDELINE; STROKE; WORLD HEALTH ORGANIZATION; ARTICLE; CHINA; CLINICAL TRIAL; ETHNOLOGY; HUMAN;

ANGINA PECTORIS; ANTIHYPERTENSIVE AGENTS; ARRHYTHMIA; CALCIUM CHANNEL BLOCKERS; CHINA; CLINICAL TRIALS; HUMAN; HYPERTENSION; NIFEDIPINE; VERAPAMIL; HUMANS;

EID: 0036023236     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (20)

1. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease
2. Calcium-channel blockade and incidence of cancer in aged populations
3. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old
4. Is it safe to use calcium channel blockers in hypertension?
5. Shanghai trial of nifedipine in the elderly (STONE)
6. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
7. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
8. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study
9. Randomised trial of effects of calcium antagonists compared with diuretics and betablockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study
10. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
11. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
12. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
13. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A meta-analysis of randomised controlled trials
14. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
15. Selection of initial antihypertensive drug therapy
16. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
17. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
18. Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: One year analysis
19. Relative efficacy and tolerability of lacidipine and amlodipine in patients with mild-to-moderate hypertension: A randomized double-blind study
20. Amlodipine, felodipine, and isradipine in the treatment of Chinese patients with mild-to-moderate hypertension